ArticleBlood advances2022

D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study.

Gualtiero Palareti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.